InVision announced it received $21 million in Series B funding with existing investor Tiger Global Funding leading the round, joined by FirstMark Capital and other existing investors.
Developer Kiwi secured another $15 million as it closed its Series B funding, with Northgate Capital leading the round along with other investors DFJ Venture and Sequioa Capital.
Backed by Norwest Venture Partners, New Enterprise Associates (NEA), SingTel Innov8 of the SingTel Group, and an undisclosed global bank, Bitglass reportedly received additional $25 million in Series B funding. Norwest and NEA were also among its investors in the earlier round, where it got $10 million. The company plans to use the new investment to expand sales, marketing and technology development.
Seattle-based Juno Therapeutics announced it has closed Series B round of funding with $134 million. The new funding came from previous investors including ARCH Venture Partners, Alaska Permanent Fund, Bezos Expedition, the personal investment company of Amazon founder Jeff Bezos, and Venrock. Also participating in Series B are 10 other mutual funds and healthcare-related funds that wish to remain anonymous.
Seoul-based Spoqa has raised $3.9 million in Series B funding from Daesung Private Equity Group and Bokwang Investments, and plans to use the investment for expansion in Japan.
As part of its expansion plans in Japan and mainland China, Hong Kong-based 8 Securities managed to raise $9 million in a Series B funding round. Velocity Capital and Leitmotiv Private Equity returned as its investors.
Following its $8.9 million Series B capital raise in March, Okyanos Heart Institute is rapidly approaching the day when it will be able to treat the first heart patient using autologous adipose derived regenerative cells (ADRCs) in the Bahamas. Adipose, or fat, is the richest source of regenerative cells in the body and the term "autologous" simply means that the cells are derived from the same patient undergoing the cell therapy treatment.
NEW YORK, NY and BOULDER, CO - DH Capital, LLC, an investment banking firm serving companies in the Internet infrastructure, communications and SaaS sectors, is pleased to announce that it served as financial advisor to Infrascale, a leader in cloud-based data protection solutions, in its recently closed $16.3 million Series B round of funding, led by new investor Carrick Capital Partners.
Business startup Zenefits has raised another $66.5 million from investors, months after its first capital-raising, following a pattern set previously by a handful of hot, young consumer companies that proved their worth to investors over a short span.
Adform, (www.adform.com), the premier ad tech partner for media agencies, trading desks, advertisers and publishers in Europe, today announced it has raised $5.5 million in a Series B funding round from new Via Venture Partners.
Chase Pharmaceuticals Corporation raises $21 million in a Series B financing round led by New Rhein Healthcare Investors, LLC.
India-based LimeRoad, an online ecommerce company, lands a $15 million Series B funding round led by Tiger Global on Tuesday. Other participants include Lightspeed Venture Partners and Matrix Partners India.
San Francisco, California-based website testing and optimization platform Optimizely raised $57 million in a Series B funding round led by Andreessen Horowitz to hire as many as 250 additional staff within this year.
Irvine, US-based fitness trainer app PEAR Sports took home $5 million in its Series B funding led by previous backers Innovate Partners and Nordic Ventures to ramp up its marketing efforts and third-party sales.
Fremont, US-based intellectual property (IP) management firm Lecorpio bagged $10 million in an unneeded funding round with Los Angeles-based investor M2O to guarantee the safe exchange of ideas and information for its enterprise clients.
Subscribe to VCpost newsletter
- Heineken to sell Mexican can, bottle maker to Crown
- New Apple iPhone to have 'mobile wallet' function: Bloomberg
- Modi seeks Japan's help for 'inclusive vision' on first big trip
- China's Li Ning stumbles from gold medal position to no man's land
- From Seoul to Mexico City, pressure mounts to ease U.S. oil export ban
- 'Back to normal' for AstraZeneca CEO, despite Pfizer rumors
- Samsung Heavy to absorb Samsung Engineering for $2.5 billion
- Microsoft will not hand over overseas email, despite order